Activity Of Ethanol Extracts 70%, Extract Nanoparticles And Nanoparticles Tablet Of Okra Fruit Extract(Abelmoschus esculentus (L) Moench.) As Anti-Dislipidemia In Rats Feeded On High Fat Diet
Abstract
Dyslipidemia is a condition caused by disruption of lipid metabolism due to the interaction of genetic factors and environmental factors. There is strong evidence of an association between LDL cholesterol and cardiovascular events based on clinical outcome studies, so LDL cholesterol is the main target in the management of dyslipidemia. In addition to using synthetic drugs, dyslipidemia can be treated by consuming natural ingredients, one of which is okra (Abelmoschus esculentus (L) Moench). The form of nanoparticles and nanoparticle tablets of okra fruit extract is an effort to increase antidyslipidemic activity and to make it easier to use. This study aims to obtain nanoparticle extracts and nanoparticle tablets of okra fruit extract which have antidyslipidemic activity in vivo against mice given the High Fat Diet (HFD). The research used 24 rats divided into 6 treatment groups, namely group I as normal control, group II as positive control using simvastatin as the control control, group III as a negative control, group IV as a control treatment of ethanol extract 70% okra fruit, group V as a control treatment of okra fruit extract nanoparticles, and group VI as a treatment of okra fruit extract nanoparticles tablets. All test substances are given for 14 days. Blood sampling was carried out on days 0, 14, and 28, with the parameters measured were lipid profiles including total cholesterol (KT), LDL, Triglycerides (TG) and HDL. 70% ethanol extract, extract nanoparticles, and okra fruit extract nanoparticle tablets can decrease KT levels by 33.14%, 46.31%, 45.42%, decrease TG levels by 39.46%, 43.56%, 41, 62%, decrease LDL levels by 45.22%, 68.76%, 59.94%, and can increase HDL levels by 103.80%, 119.20%, 114.39%. Based on the lipid profile of mice given HFD, 70% ethanol extract, nanoparticles, and okra fruit extract nanoparticle tablets had antidyslipidemic activity.
References
2. Marks DB, Marks AD, Smith CM, 2000. Biokimia Kedokteran Dasar: Sebuah Pendekatan Klinis. Pendit BU, penerjemah; Suyono J, Sadikin V,Mandera LI, editor. Jakarta: Penerbit Buku Kedokteran EGC. Terjemahan dari: Basic Medical Biochemistry: A Clinical Approach. hlm 514, 517-518.
3. Hernani, Rahardjo M. 2005. Tanaman Berkhasiat Antioksidan. Jakarta: Penebar Swadaya. hlm 17.
4. Latifah, Maya Nur. Uji Aktivitas Antikolesterol Ekstrak Etanol 70% dan Nanopartikel Ekstrak Buah Okra (Albelmoschus esculantus (L) Moench Secara In Vivo (skripsi). Jakarta: Fakultas Farmasi Universitas Pancasila; 2018.
5. Vindika, at all. Cardio protective activity of Abelmoschus esculentus (Okra). International Journal of Food Science and Nutrition. 2018. 39-43.
6. Parrot L, Eugene. Pharmaceutical Technology Minnoeapolis. Burgers. Publishing Company. 1971. Hal 73-79;82.
7. Buzea, C., Blandino, I.I.P., dan Robbie, K., 2007, Nanomaterial and nanoparticles: sources and toxicity, Biointerphases, 2 : MR170–MR172
8. Rizky Oktavia . Pengaruh Pemberian Rebusan Air Daun Kembang Sepatu (Hibiscus rosa-sinensis L.) Terhadap Kadar Lipid Darah Tikus DislipidemiA (skripsi). Jakarta: Fakultas Farmasi Universitas Pancasila; 2015.
9. Maulana, Firman. 2008. Perbandingan Pemberian Minyak Kelapa Murni (VCO) Dengan Dimvastatin Terhadap Kadar LDL Dan HDL Serta Gambaran Histopatologi Hati Pada Tikus Putih (Rattus novergicus) (skripsi). Jakarta: Fakultas Farmasi Universitas Pancasila.
10. Baraas, F. Mencegah Serangan Penyakit Jantung dengan Menekan Kolesterol, Jakarta: Kardia Iqratama, 2003.
11. Wahyudi, Tri. dkk. Profil Lipoprotein Plasma Tikus dalam Kondisi Hiperglikemia. Indonesia Mediscus Veterinus. 2015;4(2)(2301-7848): h. 1-6
12. Riesanti, Diajeng Galuh. dkk. Kadar HDL, Kadar LDL dan Gambaran Histopatologi Aorta Pada Hewan Model Tikus (Rattus norvegicus) Hiperkoletrolemia Dengan Terapi Ekstrak Air Benalu Mangga (Dendrophthoe pentandra). Jurnal. Malang. 2015. hal. 4-5
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.